Long-term cure rates for advanced rectal cancer are disappointing [1, 2] . Extensive local growth of rectal carcinoma without evidence of extrapelvic dissemination occurs infrequently but does represent a small number of potentially curable neoplasms. Such lesions may present with bulk-related problems such as pelvic pain and lower colonic obstruction or with abnormal fistulous communication between the rectum, the vagina, or the bladder [3-51. Efficacious surgical therapy requires radical en bloc removal of all pelvic viscera if cure is to be achieved in this selected group of patients.
Pelvic exenteration is a formidable surgical challenge (with potentially prohibitive morbidity and mortality) and should be considered only in centers where multidisciplinary expertise [6] is available. This report describes a group of patients with locally advanced rectal cancer confined to the pelvis who underwent pelvic exenteration at the University of Michigan Medical Center and the Ann Arbor Veterans Administration
Hospital.
Material and Methods
Between 1964 and 1976, 12 patients underwent synchronous pelvic exenteration for locally advanced (Dukes' B and C class) cancers of the rectum. There were five women and seven men. The age distribution was 46 to 68 years, with a mean age of 56.5 years. None of the patients had undergone previous pelvic irradiation or had a history of precancerous colorectal lesions. Passage of blood per rectum was the most frequent presenting symptom (10 of 12 patients), and genitourinary complaints were limited to those patients (7 of 12) with rectovesical or vaginal fistulas. Other common complaints included changes in bowel habits and weight loss (Table  I) .
All lesions were solitary and situated in the distal sigmoid and rectum with approximately equal site distribution. Resected lesions were either Dukes' B (7 of 12) or C (5 of 12) classification and none were deemed incurable on the basis of local mestastases (Table I) .
Supravesical urinary diversion was required in 10 of 12 patients and was accomplished by construction of ileal(4 of 10) and sigmoid conduits (6 of 10).
Treatment and Results
Ten patients underwent total pelvic exenteration; the remaining 2 underwent posterior pelvic exenteration alone. Resectability was determined at operation and assessed by (1) meticulous abdominal exploration to rule out distal metastases, (2) excision and frozen section evaluation of inferior mesenteric and para-aortic lymph nodes, (3) perivesical exploration to determine lateral and anterior fixation, and (4) presacral exploration to assess posterior fixation. After en bloc resection of pelvic viscera, the peritoneal floor was reconstructed with a free peritoneal graft [ 71. Ureteroenteric anastomoses to an isolated ileal or sigmoid conduit were created with a three-point triangulation technique and interrupted absorbable sutures [8] .
One operative death occurred 2 days after pelvic exenteration, yielding an operative mortality rate of 8.3 per cent. Follow-up was complete in the remaining 11 patients.
Fourteen postoperative complications occurred in nine patients (1.5 complications per patient). Mechanical small bowel obstruction (3 of 14) and wound infection (2 of 14) accounted for the majority of early complications. Late complications included pelvic recurrence (4 of I4), stoma1 stenosis (2 of 14), pyelonephritis or urinary calculi, or both (2 of 14), and metachronous cancer (1 of 14).
Six patients are alive and free of disease with an average survival of 48 months (range 10 to 76). (Figure 1 ). Although the number of patients was small, extended survival and pelvic recurrence did not correlate with local extent of spread if all disease was confined to the pelvis. Tumor differentiation (Table III) contiguous pelvic structures occurs infrequently (in years, the 5 year survival rate (40 per cent overall) [9] 5 to 6 per cent of cases) [3, 13] and may require exremains essentially unchanged. Gilbertsen [IO] has tended surgical excision to encompass the neoplasm. demonstrated that in terms of potential clinical cure, Appelby in 1950 observed that in 13 of 19 such pathe standard Miles procedure is superior to operatients treated with standard abdominoperineal retions that preserve the anal sphincter for advanced section "everyone had eventually extensive local rectal lesions, but the high recurrence rate (30 to 41 recurrence with miserably invasive growths, fistulous per cent) [lO,ll] and suboptimal survival (26 per cent abscesses, strangury, prolonged agony and stench" at 5 years) reflect the continuing need for improved [13] . The 33 to 75 per cent [3, 14] occurence of neodiagnostic and therapeutic methods.
plastic (as opposed to inflammatory) fixation plus the The tendency of some rectal cancers to exhibit early transmural spread but at the same time to stay Preoperative clinical assessment of resectability and potential curability remains a problem. The contraindications to total pelvic exenteration include extrapelvic metastases, bilateral obstructive uropathy, sciatic nerve pain, leg edema, and invasion of the bony pelvis [21] . The contraindications must be individualized because palliation can often be achieved. Several authors have reported 2 year survival rates of up to 22 per cent ,afterjpalliative pelvic extenteration [22, 23] . The use of preoperative pelvic lymphangiography, pelvic skeletal tomography, and radionuclide bone scans may further improve survival by allowing better patient selection.
The biologic peculiarities of locally advanced rectal carcinoma that is confined entirely to the pelvis warrant aggressive surgical therapy in this small group of patients. (Table IV) , and thus provides some degree of optimism to a group of patients previously labelled terminal.
The potential value of adjunctive radiation therapy is unclear. Stevens et al [24] demonstrated a 55 per cent resectability rate after high dose (5,000 rads) pelvic irradiation in 34 patients considered inoper- able because of pelvic fixation. Five of 20 patients (20 per cent) survived after operation for various periods of time. In spite of improved resectability rates after high dose pelvic irradiation, studies from the Veterans Administration [25] and by Stearns et al [26] have shown no improvement in overall survival among patients with lymph node metastases and no tumor fixation after pelvic irradiation followed by surgery. More conclusive randomized prospective studies are required to either refute or affirm the role of radiation therapy in managing cancers of the rectum and rectosigmoid.
It is difficult to define the term inoperable in reference to extensive pelvic cancers. Other than symptoms and signs of major vascular, neural, or skeletal invasion, sheer bulk does not preclude curative resection. Surgical endeavors become selfdefeating when en bloc resectional therapy is compromised by shaving tumor off adjacent structures, a practice that should be discouraged. Synchronous multivisceral pelvic excision [27] is an established method of managing pelvic cancers; acceptable methods of supravesical urinary diversion further enhance the quality of life for these patients.
Summary
Twelve patients with advanced rectal cancer and no evidence of extrapelvic metastases underwent pelvic exenteration. The operative mortality rate was 8.3 per cent. Determinate 3 and 5 year survival rates of 54 and 37 per cent were achieved. Criteria for the selection of patients and techniques of supravesical urinary diversion are discussed.
